Claim Missing Document
Check
Articles

Found 3 Documents
Search

Recurrent Giant Parasagittal Meningioma WHO Grade I: A Case Report Highlighting the Challenges of Management and the Role of Molecular Markers Sumargo, Sheila; Selfy Oswari; Guata Naibaho; Roland Sidabutar
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 8 No. 12 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v8i12.1141

Abstract

Background: Meningiomas are common intracranial tumors, but their recurrence, especially in giant parasagittal locations, presents significant management challenges. This case report underscores these challenges and emphasizes the potential role of molecular markers in improving prognostication and treatment strategies. Case presentation: A 31-year-old female presented with recurrent giant parasagittal meningioma WHO Grade I. She underwent multiple surgeries and embolizations due to persistent tumor regrowth despite histologically benign features. The tumor's location, size, and involvement of critical structures posed surgical difficulties, highlighting the limitations of current management approaches. Conclusion: This case emphasizes the need for a more nuanced understanding of meningioma recurrence beyond histological grading. Molecular markers may offer valuable insights into tumor behavior and guide personalized treatment decisions, potentially improving outcomes for patients with recurrent meningiomas.
Recurrent Giant Parasagittal Meningioma WHO Grade I: A Case Report Highlighting the Challenges of Management and the Role of Molecular Markers Sumargo, Sheila; Selfy Oswari; Guata Naibaho; Roland Sidabutar
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 8 No. 12 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v8i12.1141

Abstract

Background: Meningiomas are common intracranial tumors, but their recurrence, especially in giant parasagittal locations, presents significant management challenges. This case report underscores these challenges and emphasizes the potential role of molecular markers in improving prognostication and treatment strategies. Case presentation: A 31-year-old female presented with recurrent giant parasagittal meningioma WHO Grade I. She underwent multiple surgeries and embolizations due to persistent tumor regrowth despite histologically benign features. The tumor's location, size, and involvement of critical structures posed surgical difficulties, highlighting the limitations of current management approaches. Conclusion: This case emphasizes the need for a more nuanced understanding of meningioma recurrence beyond histological grading. Molecular markers may offer valuable insights into tumor behavior and guide personalized treatment decisions, potentially improving outcomes for patients with recurrent meningiomas.
Predictor of Percutaneous Radio-Frequency Rhizotomy Outcomes for Trigeminal Neuralgia: A Single Center Prospective Cohort Study Mustaqim Prasetya; Aji Wahyu Wardhana; Peter Adidharma; Rezka Fadillah Yefri; Adi Sulistyanto; Fadhil Fadhil; Selfy Oswari; Ryan Rhiveldi Keswani; Muhammad Kusdiansah; Yunus K. Aji; Abrar Arham
Asian Australasian Neuro and Health Science Journal (AANHS-J) Vol. 8 No. 01 (2026): AANHS Journal
Publisher : Talenta Universitas Sumatera Utara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32734/aanhs-j.v8i01.25357

Abstract

Background: Percutaneous radiofrequency rhizotomy (PRFR) offers a minimally invasive alternative for trigeminal neuralgia (TN) patients who are ineligible for microvascular decompression (MVD) or who suffer from refractory TN following MVD. However, clinical outcome predictors for PRFR, particularly in low-to-middle-income countries, remain insufficiently documented. Objectives: This study aims to (1) present the clinical characteristics of patients undergoing PRFR at a national tertiary brain center, and (2) identify clinical variables that predict optimal surgical outcomes. Methods: This prospective cohort study included 37 surgery-naïve and post-MVD recurrent TN patients who underwent PRFR between 2014 and 2020. Patient characteristics and offending pathologies were documented. Postoperative outcomes were assessed using the Barrow Neurological Institute (BNI) scales and the Numerical Rating Scale (NRS). Univariate and bivariate analyses were utilized to construct prediction models. Results: The cohort had a mean age of 59 ± 15 years. Among the patients, 51.4% were surgery-naïve, while 48.6% had a history of previous MVD. The PRFR procedure yielded significant NRS improvements in both the surgery-naïve (p < 0.001) and post-MVD (p = 0.001) groups, with no statistically significant difference in pain reduction between the two (p = 0.151). Preoperative identification of the offending pathology was a significant predictor of surgical success (p = 0.019), with small artery compression showing the highest rate of satisfactory outcomes. Conclusion: PRFR provides profound and immediate pain relief for both surgery-naïve patients and those with post-MVD recurrences. The nature of the offending pathology serves as a crucial clinical predictor for achieving optimal outcomes, making PRFR a highly reliable and cost-effective therapeutic pillar in the management of refractory TN.